Erratum to: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage
© The Author(s). 2017
Received: 24 July 2017
Accepted: 25 July 2017
Published: 4 August 2017
The original article was published in Journal of Neuroinflammation 2016 13:169
After publication of the article , it has been brought to our attention that one of the authors has had their name spelt incorrectly. The fourth author should be “Yuqi Wang”. This has been updated in the original version of the article.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Abad C, Jayaram B, Becquet L, Wang Y, O’Dorisio M, Waschek J, et al. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage. J Neuroinflammation. 2016;13:1. doi:10.1186/s12974-016-0626-3.View ArticleGoogle Scholar